[ 登录] [ 免费注册]
试剂仪器? title=
位置9a href="/">首页> 产品庒/a> > Z-IETD-FMK
立即咨询
咨询类型9/div>
*姓名9/div>
*电话9/div>
*单位9/div>
Email9/div>
*留言内容9/div>
请详细说明您的需求
*验证码:
Z-IETD-FMK
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验、/div>
Z-IETD-FMK图片
CAS NO: 210344-98-2
规格: ?8%
包装与价格:
包装 价格(?
2mg 电议
5mg 电议
10mg 电议
25mg 电议
50mg 电议
100mg 电议

产品介绍
理化性质和储存条仵/div>
Molecular Weight (MW) 654.68
Formula C30H43FN4O11
CAS No. 210344-98-2
Storage -20 for 3 years in powder form
-80 for 2 years in solvent
Solubility(In vitro) DMSO: 91 mg/mL (138.99 mM)
Water:<1 mg/mL (slightly soluble or insoluble)
Ethanol: <1 mg/mL
Other info

Synonym: Z-IE(OMe)TD(OMe)-FMK; Granzyme B Inhibitor III; Z-IETD-FMK; Z-Ile-Glu(OMe)-Thr-Asp(OMe)-CH2F.

Chemical Name: (5S,8S,11S,14S)-5-((S)-sec-butyl)-8-(2-carboxyethyl)-14-(2-fluoroacetyl)-11-((R)-1-hydroxyethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13-tetraazahexadecan-16-oic acid

InChi Key: CTXDBLYOEUERAT-VUVYEONESA-N

InChi Code: InChI=1S/C28H39FN4O11/c1-4-15(2)23(33-28(43)44-14-17-8-6-5-7-9-17)26(41)30-18(10-11-21(36)37)25(40)32-24(16(3)34)27(42)31-19(12-22(38)39)20(35)13-29/h5-9,15-16,18-19,23-24,34H,4,10-14H2,1-3H3,(H,30,41)(H,31,42)(H,32,40)(H,33,43)(H,36,37)(H,38,39)/t15-,16+,18-,19-,23-,24-/m0/s1

SMILES Code: O=C(O)C[C@@H](C(CF)=O)NC([C@H]([C@H](O)C)NC([C@H](CCC(O)=O)NC([C@H]([C@@H](C)CC)NC(OCC1=CC=CC=C1)=O)=O)=O)=O

Chemical Name L-Threoninamide, N-[(phenylmethoxy)carbonyl]-L-isoleucyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-, methyl ester
实验参考方泔/div>
In Vitro Z-IETD-FMK, which inhibits the cleavage of caspase-8 and partially inhibits the cleavage of caspase-3 and PARP, prevents the execution of apoptosis in retinal cells exposed to different apoptotic stimuli. Z-IETD-FMK (50 μM) reduces ceramide-induced cardiomyocyte death and significantly inhibits the activation of caspase 3.
In Vivo In vivo, inhibition of caspase-8 by Z-IETD-FMK reduces memory/activated CD4 and CD8 T cells, and increases susceptibility to T. cruzi infection. Z-IETD-FMK promotes neuronal survival and regeneration of injured retinal ganglion cells after CNS injuries.
Animal model T. cruzi-infected mice
Formulation & Dosage DMSO/PBS (15%); 0.4 mg/3 days
References [1] Silva EM, et al. J Immunol. 2005, 174(10), 6314-6321. [2] Monnier PP, et al. J Neurosci. 2011, 31(29), 10494-10505.
生物活?/div>




Caspase-8 and caspase-3 processing in newly activated T cells without apoptotic phenotype. Toxicol Appl Pharmacol. 2012 Nov 15;265(1):103-12.
Baidu
map